A major limitation of these studies, and indeed of using IL-1 family members as potential biomarkers of TB, relies on the difficulty in drawing the threshold of their production relevant to each clinical scenario, an issue that warrants further investigation. The gene discussed is IL1B; the disease is tuberculosis.